CIK 0000949858 · Non-accelerated filer<br>Smaller reporting company
ACHIEVE LIFE SCIENCES, INC.
Sign in to watch- Ticker
- ACHV
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 954343413
- Phone
- 425-686-1500
- Business address
- 22722 29TH DR. SE, SUITE 100, SEATTLE, WA, 98021
- Former names
- ONCOGENEX PHARMACEUTICALS, INC., SONUS PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $175,177
- in 1 filing
Net −$175,177. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-04-19 | Wan Jerry Principal Accounting Officer | Option exercise | +5,625 | 12,057 | ||
| 2024-04-19 | Wan Jerry Principal Accounting Officer | Shares withheld for taxes | −2,250 | $4.51 | $10K | 9,807 |
| 2024-04-19 | Wan Jerry Principal Accounting Officer | Option exercise · Performance Restricted Stock Unit (PRSU) | −5,625 | 0 | ||
| 2024-04-19 | JACOBS CINDY President & CMO | Option exercise | +16,250 | 34,511 | ||
| 2024-04-19 | JACOBS CINDY President & CMO | Shares withheld for taxes | −3,957 | $4.51 | $18K | 30,554 |
| 2024-04-19 | JACOBS CINDY President & CMO | Option exercise · Performance Restricted Stock Unit (PRSU) | −16,250 | 0 | ||
| 2024-04-19 | Stewart Richard Alistair Executive Chairman | Option exercise | +22,500 | 61,001 | ||
| 2024-04-19 | Stewart Richard Alistair Executive Chairman | Shares withheld for taxes | −10,125 | $4.51 | $46K | 50,876 |
| 2024-04-19 | Stewart Richard Alistair Executive Chairman | Option exercise · Performance Restricted Stock Unit (PRSU) | −22,500 | 0 | ||
| 2024-04-19 | Bencich John CEO | Option exercise | +25,000 | 101,724 | ||
| 2024-04-19 | Bencich John CEO | Shares withheld for taxes | −6,088 | $4.51 | $27K | 95,636 |
| 2024-04-19 | Bencich John CEO | Option exercise · Performance Restricted Stock Unit (PRSU) | −25,000 | 0 | ||
| 2024-03-04 | Stewart Richard Alistair Executive Chairman | Purchase | +10,000 | $4.59 | $46K | 38,501 |
| 2024-03-04 | Stewart Richard Alistair Executive Chairman | Purchase · Common Stock Warrants (right to buy) | +10,000 | 10,000 | ||
| 2024-03-04 | Bencich John CEO | Purchase | +10,000 | $4.59 | $46K | 76,724 |
| 2024-03-04 | Bencich John CEO | Purchase · Common Stock Warrants (right to buy) | +10,000 | 10,000 | ||
| 2024-01-22 | Martell Bridget A Director | Grant or award · Stock Option (right to buy) | +31,500 | 31,500 | ||
| 2024-01-22 | KING THOMAS BRAXTON Director | Grant or award · Stock Option (right to buy) | +31,500 | 31,500 | ||
| 2024-01-22 | Duty Stuart Director | Grant or award · Stock Option (right to buy) | +31,500 | 31,500 | ||
| 2024-01-22 | Sellig Thomas Director | Grant or award · Stock Option (right to buy) | +31,500 | 31,500 |
Page 5 of 36 · 715 trades